C4 Therapeutics, Inc. (CCCC)
4.11
+0.11
(+2.75%)
USD |
NASDAQ |
Aug 24, 16:00
4.07
-0.04
(-0.97%)
After-Hours: 20:00
C4 Therapeutics 1 Year Total Returns (Daily) : 53.26% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 53.26% |
| August 20, 2026 | 55.00% |
| August 19, 2026 | 52.54% |
| August 18, 2026 | 46.15% |
| August 17, 2026 | 73.37% |
| August 14, 2026 | 80.43% |
| August 13, 2026 | 75.11% |
| August 12, 2026 | 74.11% |
| August 11, 2026 | 59.92% |
| August 10, 2026 | 44.80% |
| August 07, 2026 | 44.57% |
| August 06, 2026 | 85.71% |
| August 05, 2026 | 80.10% |
| August 04, 2026 | 71.90% |
| August 03, 2026 | 65.09% |
| July 31, 2026 | 69.76% |
| July 30, 2026 | 69.44% |
| July 29, 2026 | 56.44% |
| July 28, 2026 | 62.84% |
| July 27, 2026 | 58.85% |
| July 24, 2026 | 48.47% |
| July 23, 2026 | 50.83% |
| July 22, 2026 | 68.47% |
| July 21, 2026 | 68.72% |
| July 20, 2026 | 54.31% |
| Date | Value |
|---|---|
| July 17, 2026 | 69.27% |
| July 16, 2026 | 77.23% |
| July 15, 2026 | 80.09% |
| July 14, 2026 | 60.08% |
| July 13, 2026 | 75.78% |
| July 10, 2026 | 104.0% |
| July 09, 2026 | 112.4% |
| July 08, 2026 | 145.0% |
| July 07, 2026 | 186.2% |
| July 06, 2026 | 179.7% |
| July 02, 2026 | 182.9% |
| July 01, 2026 | 187.4% |
| June 30, 2026 | 226.6% |
| June 29, 2026 | 210.7% |
| June 26, 2026 | 180.3% |
| June 25, 2026 | 185.7% |
| June 24, 2026 | 172.4% |
| June 23, 2026 | 187.1% |
| June 22, 2026 | 190.1% |
| June 18, 2026 | 188.2% |
| June 17, 2026 | 163.1% |
| June 16, 2026 | 135.6% |
| June 15, 2026 | 127.4% |
| June 12, 2026 | 140.7% |
| June 11, 2026 | 154.6% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Cartesian Therapeutics, Inc. | -8.39% |
| Beam Therapeutics, Inc. | 85.88% |
| Rallybio Corp. | 254.2% |
| Q32 Bio, Inc. | 751.7% |
| Arrowhead Pharmaceuticals, Inc. | 319.8% |